Government Relations Committee

The Government Relations Committee develops relationships with government entities, including the NIH, Congress, and CMS. The duties of the committee include recommending policy positions that support gene and cell therapy research, development, and access, as well as responsible use of these technologies; and recommending educational programming that addresses major policy issues in the field.
Full NamePositionOrganizationTerm StartTerm End
Christina M. MarkusChairKing & Spalding2/1/20265/31/202747509
Lauriel Earley, PhDMemberEarley Stage Gene Therapy Consulting6/1/20265/31/202921413
Cara O’Neill, MDMemberCure Sanfilippo Foundation6/1/20255/31/202856860
Anna GriffinMemberGilead6/1/20245/31/202746075
Ashley HumeMemberEmerging Therapy Solutions6/1/20255/31/202842565
Max BronsteinMemberAviva Strategies6/1/20265/31/202928767
Emily MaceMemberAstraZeneca10/20/20255/31/2028104573
Nidhi Kotecha, PhDMemberGates Institute6/1/20255/31/202872300
Lisa Kahlman, JDMemberUltragenyx Pharmaceutical Inc.6/1/20255/31/202847728
Andrew Dale CampbellMemberChildren's National Hospital6/1/20255/31/202873570
Gary L. Buchschacher, Jr., MD, PhDMemberKaiser Permanente Southern California6/1/20245/31/20276833
Maria BonnevilleMemberCIRM6/1/20245/31/202772273
Susan Matesanz, MDMemberChildren's Hospital of Philadelphia6/1/20245/31/202771452
Scott V. McGoohan, JD, BSMemberVertex Pharmaceuticals6/1/20235/31/202931022
Claire WhiteMemberCHOP6/1/20255/31/202865865
Kim CoheeMemberTenaya Therapeutics6/1/20265/31/202999076
Adriana Bankston, PhDMemberFormerly U.S. House of Representatives5/31/20255/31/202873474
Christina MayerStaff LiaisonASGCT6/1/20195/31/204535375